Covariates | Overall survival | Disease-free survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Age (> 60Y vs. ≤ 60Y) | 0.80 (0.28–2.31) | 0.682 | 0.04 (0.00–36.60) | 0.35 | ||||
Sex (M vs. F) | 1.29 (0.63–2.66) | 0.485 | 1.89 (0.58–6.23) | 0.293 | ||||
PS (> 1 Y vs. ≤ 1) | 1.24 (0.50–3.04) | 0.642 | 0.04 (0.00–23.31) | 0.317 | ||||
PIF (yes vs. no) | 7.8 (3.2–19.2) | < 0.001 | 6.9 (2.7–17.9) | < 0.001 | 2.5 (0.52–11.92) | 0.296 | ||
FAB (M4 vs. M5) | 0.74 (0.36–1.52) | 0.412 | 0.61 (0.19–1.98) | 0.409 | ||||
Intensive induction (yes vs. no) | 0.64 (0.31–1.32) | 0.226 | 4.83 (0.99–23.59) | 0.052 | 6.98 (0.69–70.77) | 0.1 | ||
Initial PB blast % | 1.00 (0.99–1.02) | 0.552 | 1.02 (1.00–1.04) | 0.055 | 1.05 (0.99–1.10) | 0.092 | ||
Initial BM blast % | 1.00 (0.99–1.02) | 0.693 | 1.00 (0.98–1.03) | 0.797 | ||||
Initial TLC × 109/L | 1.00 (0.99–1.01) | 0.989 | 1.02 (1.00–1.04) | 0.058 | ||||
Cytogenetics (favorable vs. others) | 0.05 (0.00–56.25) | 0.394 | 0.04 (0.00–36.60) | 0.35 | ||||
Monocytopenic (yes vs. no) | 1.91 (0.90–4.04) | 0.091 | 1.03 (0.46–2.34) | 0.941 | 3.65 (1.22–10.93) | 0.021 | 1.26 (0.10–15.43) | 0.856 |
Initial PLT × 109/L | 1.00 (1.00–1.01) | 0.002 | 1.00 (0.99–1.04) | 0.338 | 0.99 (0.97–1.01) | 0.686 | ||
Initial Hb g/dL | 1.03 (0.85–1.25) | 0.75 | 1.06 (0.77–1.47) | 0.715 |